AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Events

AGORA PRS Seminar | December 9th

More information

Events

AGORA Christmas | December 11th

More information

Events

Ludwig Distinguished Lecture, Prof. Wendy Garrett | December 16th

More information

News

TANDEM grant call 2026

News

Life in Real-Time: A Conversation with Alexandre Bénéchet, Head of the IVIF Facility

Events

AGORA Single-cell omics meetings

More information

Highlight

AGORA Scientists Rank Among World’s Top 1% Most-Cited Researchers in 2025

Highlighted publication

Multi-cellular phenotypic dynamics during the progression of an immunocompetent breast cancer model.

Gsell L, Watson SS, Sutevski I, (…), Cougnoux A, Joyce JA, Hausser J

iScience – 2025 Nov 21

Highlighted publication

Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma.

de Sostoa J, Marinari E, Pedard M, (…), Orend G, Dutoit V, Migliorini D

Journal for immunotherapy of cancer – 2025 Nov 4

Highlighted publication

Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapy.

Rath JA, Rudden LSP, Nouraee N, (…), Chatzi Souleiman A, Barth P, Arber C

Nature biomedical engineering – 2025 Oct 28

Highlighted publication

Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models.

Ghasemi A, Martinez-Usatorre A, Liu Y, (…), Speiser DE, Migliorini D, De Palma M

Nature Communications – 2025 Oct 15

News

AGORA Researchers Awarded Prestigious SNSF Project Funding Grants

Past news

Latest publications

Equilibrium state dynamics-based modeling of temporal dose delivery dependencies of FLASH skin sparing.

Böhlen TT, Grilj V, Sesink A, (…), Bochud F, Herrera FG, Moeckli R

Medical physics – 2025 Dec 1

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Coukos G, Donia M, Gastman BR, (…), Wagner PL, Yang JC, Lotze MT

Journal for immunotherapy of cancer – 2025 Nov 29

Multi-cellular phenotypic dynamics during the progression of an immunocompetent breast cancer model.

Gsell L, Watson SS, Sutevski I, (…), Cougnoux A, Joyce JA, Hausser J

iScience – 2025 Nov 21

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.

Corbett RJ, Kaufman RS, McQuaid SW, (…), MacFarland SP, Rokita JL, Diskin SJ

Nature communications – 2025 Nov 21

[(99m)Tc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family.

Schottelius M, Viertl D, Buckle T, (…), Enke JS, Brosch-Lenz J, Lapa C

European journal of nuclear medicine and molecular imaging – 2025 Nov 14